Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.7808
-0.0823 (-9.54%)
At close: Mar 27, 2026, 4:00 PM EDT
0.7900
+0.0092 (1.18%)
After-hours: Mar 27, 2026, 7:36 PM EDT

Werewolf Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-60.82-70.52-37.37-53.81-49.98
Depreciation & Amortization
1.631.811.761.10.22
Stock-Based Compensation
6.258.838.017.44.1
Other Adjustments
0.861.160.882.170.52
Change in Receivables
-1.355.58-6.93-
Changes in Accounts Payable
-7.53.46-4.343.056.27
Changes in Unearned Revenue
--1.34-6.327.66-
Changes in Other Operating Activities
-0.71-0.94-0.82-1.24-3.99
Operating Cash Flow
-60.29-56.19-32.61-40.6-42.88
Capital Expenditures
--0.25-0.77-3.61-0.5
Investing Cash Flow
--0.25-0.77-3.61-0.5
Long-Term Debt Issued
-3040--
Long-Term Debt Repaid
--40---
Net Long-Term Debt Issued (Repaid)
--1040--
Issuance of Common Stock
6.0323.7518.4315.99111.81
Net Common Stock Issued (Repurchased)
6.0323.7518.4315.99111.81
Other Financing Activities
--0.67--0.09-2.38
Financing Cash Flow
6.0313.0858.4315.91109.43
Net Cash Flow
-54.26-43.3625.05-28.366.05
Free Cash Flow
-60.29-56.44-33.38-44.21-43.37
FCF Margin
--2994.27%-167.38%-269.54%-
Free Cash Flow Per Share
-1.29-1.29-0.94-1.53-2.35
Levered Free Cash Flow
-67.39-77.78-7.85-46.85-199.93
Unlevered Free Cash Flow
-67.25-70.86-50.98-49.1-48.09
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q